HEPCLUDEX
Active substance: bulevirtide
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BULEVIRTIDE ACETATE 8.5 mg/1
United StatesActive
Marketing holder: Gilead Sciences, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BULEVIRTIDE ACETATE · 8.5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-971b-72b1-8a31-15c2d46fed06;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 61958-3104
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 61958-3104 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 61958-3104 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 61958-3104 · Verified 2026-10-09 · open in source